{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:18:15Z","timestamp":1788171495943,"version":"build-2803163510"},"reference-count":27,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["25K10718"],"award-info":[{"award-number":["25K10718"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"award":["25K10718"],"award-info":[{"award-number":["25K10718"]}],"id":[{"id":"https:\/\/ror.org\/048rj2z13","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematol. Rep.","Hematology Reports"],"abstract":"<jats:p>Metallothioneins (MTs) are cysteine-rich metal-binding proteins traditionally recognized for their roles in metal homeostasis and antioxidant defense. Recent studies have revealed broader and functionally diverse roles of MT isoforms in acute myeloid leukemia (AML). This review summarizes current evidence regarding MT-mediated regulation of leukemic cell survival, differentiation, and therapy-associated stress adaptation. MT1 family members, particularly MT1X and MT1G, have been associated with proliferation, chemoresistance, and differentiation blockade in specific experimental contexts, whereas MT2A and MT3 exhibit tumor-suppressive effects in selected AML models. MT isoforms also participate in oxidative stress adaptation and redox regulation, including responses to azacitidine, doxorubicin, and ferroptotic stress. However, the available evidence is derived largely from cell-line studies, selected molecular subtypes, transcriptomic analyses, and limited primary-patient datasets. Accordingly, isoform-specific MT functions should be interpreted as context-dependent rather than uniformly applicable across AML. Further validation in independent primary AML cohorts and genetically defined subtypes is required to establish their clinical utility as biomarkers or therapeutic targets.<\/jats:p>","DOI":"10.3390\/hematolrep18050062","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:21:19Z","timestamp":1788168079000},"page":"62","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metallothionein Isoforms in Acute Myeloid Leukemia: Roles in Survival, Differentiation, and Stress Adaptation"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0011-6065","authenticated-orcid":false,"given":"Shinichiro","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai 983-8536, Miyagi, Japan"},{"name":"Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-5-41","article-title":"Molecular functions of metallothionein and its role in hematological malignancies","volume":"5","author":"Takahashi","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/15384047.2022.2054243","article-title":"MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X","volume":"23","author":"Xin","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"ref_3","first-page":"38","article-title":"Upregulation of metallothionein-1G accelerates G1\/S transition in the growth phase of acute promyelocytic leukemia NB4 cells","volume":"51","author":"Hirako","year":"2021","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41420-023-01371-8","article-title":"Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: Links to iron metabolism and metallothionein","volume":"9","author":"Grignano","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_5","first-page":"373","article-title":"Metallothionein 1 mediates growth and survival of Dnmt3a;Npm1-mutant acute myeloid leukemia","volume":"111","author":"Mistry","year":"2026","journal-title":"Haematologica"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hirako, N., Nakano, H., and Takahashi, S. (2014). A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103282"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.7150\/ijms.57821","article-title":"Effect of MT2A on apoptosis and proliferation in HL60 cells","volume":"18","author":"Pan","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1479-5876-12-182","article-title":"Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation","volume":"12","author":"Tao","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Park, H., and Miyano, S. (2024). Differential Gene Regulatory Network Analysis between Azacitidine-Sensitive and -Resistant Cell Lines. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063302"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102651","DOI":"10.1016\/j.isci.2021.102651","article-title":"Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia","volume":"24","author":"Zee","year":"2021","journal-title":"iScience"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"mfad022","DOI":"10.1093\/mtomcs\/mfad022","article-title":"Expression pattern and prognostic implication of zinc homeostasis-related genes in acute myeloid leukemia","volume":"15","author":"Zhu","year":"2023","journal-title":"Metallomics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjh.20229","article-title":"ZIP10 as a potential therapeutic target in acute myeloid leukaemia","volume":"207","author":"Rolles","year":"2025","journal-title":"Br. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ng1361","article-title":"Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1","volume":"36","author":"Rosenbauer","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2002-04-1288","article-title":"The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia","volume":"101","author":"Vangala","year":"2003","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1074\/jbc.M109.095810","article-title":"Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells","volume":"285","author":"Imoto","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/153537020322800908","article-title":"Erythropoietin-induced metallothionein gene expression: Role in proliferation of K562 cells","volume":"228","author":"Zhao","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1248\/bpbreports.3.1_34","article-title":"Cadmium Inhibits All-Trans-Retinoic Acid-Induced Increase of Nitroblue Tetrazolium Reduction Activity and Induces Metallothionein 1G Expression in Human Acute Myelocytic Leukemia HL-60 Cells","volume":"3","author":"Ogushi","year":"2020","journal-title":"BPB Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtemb.2009.02.003","article-title":"Differential quantitative zinc-induced expression of human metallothionein isogenes in haematopoietic precursor cell lines","volume":"23","author":"Rahman","year":"2009","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, S., Kim, M.J., Lee, S.H., Jin, L., Cong, W., Jeong, H.G., and Lee, K.Y. (2021). Metallothionein 3 Promotes Osteoblast Differentiation in C2C12 Cells via Reduction of Oxidative Stress. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094312"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41420-023-01729-y","article-title":"Metallothionein 3 promotes osteoclast differentiation and survival by regulating the intracellular Zn2+ concentration and NRF2 pathway","volume":"9","author":"Arisumi","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kadota, Y., Toriuchi, Y., Aki, Y., Mizuno, Y., Kawakami, T., Nakaya, T., Sato, M., and Suzuki, S. (2017). Metallothioneins regulate the adipogenic differentiation of 3T3-L1 cells via the insulin signaling pathway. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176070"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, Y., Lee, S.H., Piao, M., Kim, H.S., and Lee, K.Y. (2023). Metallothionein 3 Inhibits 3T3-L1 Adipocyte Differentiation via Reduction of Reactive Oxygen Species. Antioxidants, 12.","DOI":"10.3390\/antiox12030640"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103958","DOI":"10.1016\/j.redox.2025.103958","article-title":"Redox-dependent protein S-glutathionylation governs azacitidine sensitivity and resistance in AML","volume":"89","author":"Nemes","year":"2026","journal-title":"Redox Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00277-023-05293-4","article-title":"Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia","volume":"102","author":"Tang","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3892\/ol.2024.14707","article-title":"Ferroptosis: Potential therapeutic targets and prognostic predictions for acute myeloid leukemia (Review)","volume":"28","author":"Zhang","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12032-025-03012-9","article-title":"Targeting Nrf2 in acute myeloid leukemia: An updated review on its role in chemoresistance and emerging therapeutic strategies","volume":"42","author":"Mathew","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_27","first-page":"96","article-title":"Metallothionein 1: The Achilles heel of Dnmt3a;Npm1-mutant acute myeloid leukemia","volume":"111","author":"Yan","year":"2026","journal-title":"Haematologica"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/5\/62\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:56:21Z","timestamp":1788170181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/5\/62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["hematolrep18050062"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep18050062","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}